These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25335548)

  • 41. Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study.
    Elkashef AM; Buchanan RW; Gellad F; Munson RC; Breier A
    Am J Psychiatry; 1994 May; 151(5):752-5. PubMed ID: 7909412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
    Wong DF; Wagner HN; Tune LE; Dannals RF; Pearlson GD; Links JM; Tamminga CA; Broussolle EP; Ravert HT; Wilson AA; Toung JK; Malat J; Williams JA; O'Tuama LA; Snyder SH; Kuhar MJ; Gjedde A
    Science; 1986 Dec; 234(4783):1558-63. PubMed ID: 2878495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia.
    Lahti AC; Weiler MA; Medoff DR; Tamminga CA; Holcomb HH
    Psychiatry Res; 2005 May; 139(1):19-30. PubMed ID: 15950442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Shape changes of the basal ganglia and thalamus in Alzheimer's disease: a three-year longitudinal study.
    Cho H; Kim JH; Kim C; Ye BS; Kim HJ; Yoon CW; Noh Y; Kim GH; Kim YJ; Kim JH; Kim CH; Kang SJ; Chin J; Kim ST; Lee KH; Na DL; Seong JK; Seo SW
    J Alzheimers Dis; 2014; 40(2):285-95. PubMed ID: 24413620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.
    Buchsbaum MS; Wu JC; DeLisi LE; Holcomb HH; Hazlett E; Cooper-Langston K; Kessler R
    Biol Psychiatry; 1987 Apr; 22(4):479-94. PubMed ID: 2882788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 123I-beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia.
    Sjøholm H; Bratlid T; Sundsfjord J
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):27-31. PubMed ID: 14712338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal change in basal ganglia volume in patients with Huntington's disease.
    Aylward EH; Li Q; Stine OC; Ranen N; Sherr M; Barta PE; Bylsma FW; Pearlson GD; Ross CA
    Neurology; 1997 Feb; 48(2):394-9. PubMed ID: 9040728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone.
    Massana G; Salgado-Pineda P; Junqué C; Pérez M; Baeza I; Pons A; Massana J; Navarro V; Blanch J; Morer A; Mercader JM; Bernardo M
    J Clin Psychopharmacol; 2005 Apr; 25(2):111-7. PubMed ID: 15738741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between altered brain morphology and elevated peripheral endothelial markers--implications for psychotic disorders.
    Dieset I; Haukvik UK; Melle I; Røssberg JI; Ueland T; Hope S; Dale AM; Djurovic S; Aukrust P; Agartz I; Andreassen OA
    Schizophr Res; 2015 Feb; 161(2-3):222-8. PubMed ID: 25433965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parallel basal ganglia circuits for voluntary and automatic behaviour to reach rewards.
    Kim HF; Hikosaka O
    Brain; 2015 Jul; 138(Pt 7):1776-800. PubMed ID: 25981958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.
    Perez-Costas E; Melendez-Ferro M; Roberts RC
    J Neurochem; 2010 Apr; 113(2):287-302. PubMed ID: 20089137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study.
    Hokama H; Shenton ME; Nestor PG; Kikinis R; Levitt JJ; Metcalf D; Wible CG; O'Donnell BF; Jolesz FA; McCarley RW
    Psychiatry Res; 1995 Nov; 61(4):209-29. PubMed ID: 8748466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High energy phosphate abnormalities normalize after antipsychotic treatment in schizophrenia: a longitudinal 31P MRS study of basal ganglia.
    Jayakumar PN; Gangadhar BN; Venkatasubramanian G; Desai S; Velayudhan L; Subbakrishna D; Keshavan MS
    Psychiatry Res; 2010 Mar; 181(3):237-40. PubMed ID: 20153149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bihemispheric developmental alterations in basal ganglia volumes following unilateral perinatal stroke.
    Hassett J; Carlson H; Babwani A; Kirton A
    Neuroimage Clin; 2022; 35():103143. PubMed ID: 36002972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia.
    Okugawa G; Nobuhara K; Takase K; Saito Y; Yoshimura M; Kinoshita T
    Neuropsychobiology; 2007; 55(1):43-6. PubMed ID: 17556852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine metabolism increases in post-mortem schizophrenic basal ganglia.
    Toru M; Nishikawa T; Mataga N; Takashima M
    J Neural Transm; 1982; 54(3-4):181-91. PubMed ID: 6127373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning.
    Chand GB; Dwyer DB; Erus G; Sotiras A; Varol E; Srinivasan D; Doshi J; Pomponio R; Pigoni A; Dazzan P; Kahn RS; Schnack HG; Zanetti MV; Meisenzahl E; Busatto GF; Crespo-Facorro B; Pantelis C; Wood SJ; Zhuo C; Shinohara RT; Shou H; Fan Y; Gur RC; Gur RE; Satterthwaite TD; Koutsouleris N; Wolf DH; Davatzikos C
    Brain; 2020 Mar; 143(3):1027-1038. PubMed ID: 32103250
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by "resting state" functional magnetic resonance imaging.
    Lui S; Li T; Deng W; Jiang L; Wu Q; Tang H; Yue Q; Huang X; Chan RC; Collier DA; Meda SA; Pearlson G; Mechelli A; Sweeney JA; Gong Q
    Arch Gen Psychiatry; 2010 Aug; 67(8):783-92. PubMed ID: 20679586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.
    Mehler-Wex C; Riederer P; Gerlach M
    Neurotox Res; 2006 Dec; 10(3-4):167-79. PubMed ID: 17197367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia.
    Bustillo JR; Rowland LM; Lauriello J; Petropoulos H; Hammond R; Hart B; Brooks WM
    Am J Psychiatry; 2002 Jan; 159(1):130-3. PubMed ID: 11772701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.